11.10.2017.
New EudraVigilance system and go-live planInformation for marketing authorisation holders and sponsors of clinical trials The European Medicines Agency (EMA) informs that on 22 November 2017, EMA will launch a new and improved version of EudraVigilance, the European information system of suspected adverse reactions to medicines that are authorised or being studied in clinical trials in the European Economic Area (EEA). Read more
|
